Alzheimer Therapy May Reduce AMD Risk

 This study suggests that the use of acetylcholinesterase inhibitors, used to improve the quality of life in Alzheimer's patients, may reduce the incidence of age-related macular degeneration in patients with Alzheimer’s by 6%.   Randomized clinical trials would be necessary to truly evaluate any cause-and-effect relationship. 

Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH